Radiotherapy also displays interactions with innate and adaptive immune responses by increased expression of MHC-I and MHC-II molecules, CD80, stress ligands and death receptors on tumor cell surfaces and release of immune-activating chemokines, cytokines, exosomes and danger signals hereby recruiting DCs to the tumor site [96,97]. The gene discussed is CD80; the disease is neoplasm.